Joachim Dittrich appoints new Chief Representative of Optima

Joachim Dittrich has been appointed as Chief Representative of Optima, effective from February 2018.

The machine engineer will be responsible for the development and internationalisation, particularly for Optima Consumer, as well as for additional subsidiaries and holdings nationwide and internationally.

The area of responsibility includes the strategic orientation and development of these business sections and the development of prospects and synergies.

Dittrich will assume a large part of Hans Bühler’s the CEO, tasks for the Optima Consumer division. Hans Bühler will dedicate more of his time to overall tasks and topics regarding the consortium.

Joachim Dittrich returns to his former company, previously working for Optima Consumer from 2010 to 2011 as the Commercial Director.

You may also like

Digital

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient
Manufacturing

TrakCel to support cell and gene therapy orchestration with OCELLOS IT solution

The IT system allows cell and gene therapy (CGT) manufacturers to track the progress of personalised CGTs in real-time, while also managing their supply chain
Manufacturing

Asymchem fully automates its therapeutic peptide manufacturing processes

The company has facilitated the scale-up of its peptide manufacturing capabilities, with its production capacity now standing at 10,000 L
Manufacturing

How AI can optimise your pharmaceutical manufacturing processes and raise throughput

Artificial intelligence (AI) allows pharmaceutical manufacturers to perform predictive maintenance, which can reduce downtime and enhance process efficiency
Digital

How AI and GenAI will revolutionise the healthcare industry

Artificial intelligence — and particularly its newest iteration, generative artificial intelligence (GenAI) — could bring significant changes to the way we live, work and interact with one another
Research & Development

Xybion launches AI-enabled LIMS technology, LIMS 10.0

The laboratory information management system (LIMS) can improve a lab's functionality and efficiency for users across a vast range of industries
Digital

AI in pharma: the trends and future of the tech in the industry

AI can enhance the efficiency and cost-effectiveness of a range of processes across the pharmaceutical industry, so S&P Global explores the current scope of the tech and its future potential
Subscribe now